In the present study, we generated recombinant HAPLN1-PTR1 that exhibited improved quality and functional potency, and used it to identify critical components of a putative receptor complex through which a HAPLN1 matrikine elicits pro-tumorigenic signaling in MM cells. The gene discussed is HAPLN1; the disease is Miyoshi myopathy.